Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Chemotherapy, Adjuvant × Gynecologic × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Thoracic 1 Gynecologic 1 Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 1

Interventions

pembrolizumab 31 Paclitaxel 29 Specimen Handling 28 Carboplatin 28 Bevacizumab 25 Magnetic Resonance Spectroscopy 24 olaparib 20 Biopsy 18 Cisplatin 14 Gemcitabine 12 Taxes 10 liposomal doxorubicin 9 Nivolumab 8 Doxorubicin 8 Cyclophosphamide 8 lenvatinib 7 Fulvestrant 7 Drug Therapy 7 X-Rays 6 Radiotherapy 6 Platinum 6 trastuzumab deruxtecan 5 palbociclib 5 niraparib 5 aldesleukin 5 abemaciclib 5 Topotecan 5 Oxaliplatin 5 Letrozole 5 Immunoglobulin G 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04016142 2026-03-18

ACCRAPAN

Centre Oscar Lambret

Phase 2 Terminated

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡